Metri Bio
5 known investors
Find your way into Metri Bio
98 people in our graph share verified history with the Metri Bio team — schools, employers, funds. One of them is your warm intro.
Andrewunlockedknows Ashley Abel, Ph.D. · together at UW Medicine (overlapped)
×3knows the team · via Yale University
×2knows the team · via Brown University School of Engineering
knows the team · via Yale Biotech Club
×2knows the team · via Seattle University
knows the team · via Gameto
Metri is a biotech company developing first-in-class, disease-modifying therapeutics for endometriosis and other uterine diseases originating in the endometrium. It is building a platform to identify reliable disease targets for conditions that currently lack targeted treatments.
Founders & leadership
AA
Ashley AbelinChief Executive Officer, Co-FounderAshley Abel holds a Ph.D. in Genetics from Yale University, where she conducted research on 3D stem cell models in Prof. Berna Sozen's lab, and previously earned a B.S. in Cell and Molecular Biology from Seattle University with research experience in stem cell biology at the University of Washington and Brown University. She is CEO and co-founder of Metri Bio, a biotech company developing therapeutics for endometriosis and uterine diseases.30 Under 30 2026
AA
Ashley Abel, Ph.D.inChief Executive Officer, Co-FounderAshley Abel completed her Ph.D. in Genetics at Yale University in 2025, where she worked in stem cell modeling of human reproductive biology under Prof. Berna Sozen, and earned her B.S. in Cell and Molecular Biology from Seattle University. She is founder and CEO of Metri Bio, a biotech company developing therapeutics for endometriosis and uterine diseases.
BS
Berna Sozen, PhDAcademic Co-Founder & SAB Chair
Investors · 5
Fifty YearsSan Francisco · $250K – $2M
Pace VenturesBerlin · $550K – $1.6Mvia Marius Swart · inferred
Pillar VCBoston · $50K – $4M
Also in the syndicate · 2
Navec InvestmentsSlocum Management
Funding
SEC filings, press & company announcements$10M disclosed across 2 rounds · 2025
- $5MraisedDec 2025 · 2 sourcesSource ↗
- $5MPre-SeedDec 2025 · 5 sources
Pillar VC (lead), Navec Investments, Pace Ventures, Slocum Management
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Metri Bio do?
- Metri is a biotech company developing first-in-class, disease-modifying therapeutics for endometriosis and other uterine diseases originating in the endometrium. It is building a platform to identify reliable disease targets for conditions that currently lack targeted treatments.
- Who founded Metri Bio?
- Metri Bio was founded by Ashley Abel, Ashley Abel, Ph.D., Berna Sozen, PhD.
- Who are Metri Bio's investors?
- Metri Bio's investors include Fifty Years, Pace Ventures, Pillar VC.
- How much funding has Metri Bio raised?
- Metri Bio has disclosed $10M raised across 2 rounds.